ReviewFrontiers in pharmacology2023

The role of irreversible pan-HER tyrosine kinase inhibitors in the treatment of HER2-Positive metastatic breast cancer.

Zihong Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.